Tilray CEO: Opportunities in clinical cannabis are broad
Tilray’s inventory is up on the unusual time, but aloof down 80 p.c from a February high. CNBC’s Frank Holland reports on his dialog with Tilray CEO Irwin Simon in…
Tilray’s inventory is up on the unusual time, but aloof down 80 p.c from a February high. CNBC’s Frank Holland reports on his dialog with Tilray CEO Irwin Simon in…